Research Article

The 6-item Self-Efficacy Scale in the Management of Chronic Disease in Individuals with Multiple Sclerosis (MS-CHOYO): Validity and Reliability Study

Volume: 8 Number: 3 October 8, 2023
EN TR

The 6-item Self-Efficacy Scale in the Management of Chronic Disease in Individuals with Multiple Sclerosis (MS-CHOYO): Validity and Reliability Study

Abstract

Objective: The research was methodologically planned and applied to adapt the 6-item self-efficacy scale in chronic disease management of individuals with multiple sclerosis to Turkish society. Material and Method: The research was carried out between January 2021 and March 2021 by using the online questionnaire method with individuals with Multiple Sclerosis registered to the Turkish MS Society. To establish the validity and reliability of the self-efficacy for managing chronic disease six item scale (SEMDC- 6S), the study was carried out with a sample consisting of n=104 individuals, which was more than 10 times the number of items on the scale(six items).For test-retest reliability, the scale was administered to 20 patients twice at a two week interval. Results: The validity of the SEMDC-6S was evaluated with language validity, construct validity, and content validity. The internal consistency coefficient (Cronbach's Alpha) was 0.95, as which was very high.The item-total correlation was examined, and accordingly, no items were excluded from the scale. According to the test-retest results, it was determined that repeated measurements did not differ significantly, and retests had a high correlation. Conclusion: The SEMDC-6S, which was adapted to Turkish society, is a valid and reliable tool. We recommend that it should be applied in different groups and cultures to increase its evidence value.

Keywords

Supporting Institution

yok

Project Number

FBU/2020-24

References

  1. Kasper J, Köpke S, Mühlhauser I, Heesen C. Evidence-Based Patient Information About Treatment of Multiple Sclerosis: A Phase One Study on Comprehension and Emotional Responses. PEC J. 2006; 62:56-63.
  2. Koşar C, Besen D. Kronik Hastalıklarda Hasta Aktifliği: Kavram Analizi. Dokuz Eylül Üniversitesi Hemşirelik Fakültesi Elektronik Dergisi. 2015; 8(1):45-51.
  3. World Health Organization (WHO). Non communicable diseases progress monitor 2020. 2020a. Erişim linki: https://www.who. int/ publications/i/item/ncd-progress-monitor-2020. (Date of Access:10.10.2021).
  4. Schulman-Green D, Jaser S, Martin F, Alonzo A, Grey M, McCorkle R, et al. Processes of self-management in chronic illness. J Nurs Scholarsh. 2012; 44(2):136-144.
  5. Barlow J, Sturt J, Hearns Haw H. Self-management interventions for people with chronic conditions in primary care: Examples from arthritis, asthma and diabetes. Health Education Journal. 2002a; 61:365-378.
  6. Dufour SP, Graham S, Friesen J, Rosenblat M, Rous C, Richardson J. Physiotherapists supporting self-management through health coaching: a mixed methods program evaluation. Physiother Theory Pract. 2014; 1:1-10.
  7. Fortin M, Haggerty J, Almirall J, Bouhali T, Sasseville M, Lemieux M. Life style factor sand multimorbidity: a cross sectionalstudy. BMC Public Health. 2014; 14:686.
  8. Dorstyn D, Black R, Mpofu E, Kneebone I. Utilizingthe ICF to understand depressive symptomology in multiple sclerosis: An exploratory systematic review. Rehabil Psychol. 2017; 62(2):143-64.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Early Pub Date

October 8, 2023

Publication Date

October 8, 2023

Submission Date

February 1, 2023

Acceptance Date

May 28, 2023

Published in Issue

Year 2023 Volume: 8 Number: 3

APA
Eroğlu, N., & Temiz, G. (2023). The 6-item Self-Efficacy Scale in the Management of Chronic Disease in Individuals with Multiple Sclerosis (MS-CHOYO): Validity and Reliability Study. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, 8(3), 963-968. https://doi.org/10.61399/ikcusbfd.1245472
AMA
1.Eroğlu N, Temiz G. The 6-item Self-Efficacy Scale in the Management of Chronic Disease in Individuals with Multiple Sclerosis (MS-CHOYO): Validity and Reliability Study. İKÇÜSBFD. 2023;8(3):963-968. doi:10.61399/ikcusbfd.1245472
Chicago
Eroğlu, Nermin, and Gamze Temiz. 2023. “The 6-Item Self-Efficacy Scale in the Management of Chronic Disease in Individuals With Multiple Sclerosis (MS-CHOYO): Validity and Reliability Study”. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi 8 (3): 963-68. https://doi.org/10.61399/ikcusbfd.1245472.
EndNote
Eroğlu N, Temiz G (October 1, 2023) The 6-item Self-Efficacy Scale in the Management of Chronic Disease in Individuals with Multiple Sclerosis (MS-CHOYO): Validity and Reliability Study. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi 8 3 963–968.
IEEE
[1]N. Eroğlu and G. Temiz, “The 6-item Self-Efficacy Scale in the Management of Chronic Disease in Individuals with Multiple Sclerosis (MS-CHOYO): Validity and Reliability Study”, İKÇÜSBFD, vol. 8, no. 3, pp. 963–968, Oct. 2023, doi: 10.61399/ikcusbfd.1245472.
ISNAD
Eroğlu, Nermin - Temiz, Gamze. “The 6-Item Self-Efficacy Scale in the Management of Chronic Disease in Individuals With Multiple Sclerosis (MS-CHOYO): Validity and Reliability Study”. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi 8/3 (October 1, 2023): 963-968. https://doi.org/10.61399/ikcusbfd.1245472.
JAMA
1.Eroğlu N, Temiz G. The 6-item Self-Efficacy Scale in the Management of Chronic Disease in Individuals with Multiple Sclerosis (MS-CHOYO): Validity and Reliability Study. İKÇÜSBFD. 2023;8:963–968.
MLA
Eroğlu, Nermin, and Gamze Temiz. “The 6-Item Self-Efficacy Scale in the Management of Chronic Disease in Individuals With Multiple Sclerosis (MS-CHOYO): Validity and Reliability Study”. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, vol. 8, no. 3, Oct. 2023, pp. 963-8, doi:10.61399/ikcusbfd.1245472.
Vancouver
1.Nermin Eroğlu, Gamze Temiz. The 6-item Self-Efficacy Scale in the Management of Chronic Disease in Individuals with Multiple Sclerosis (MS-CHOYO): Validity and Reliability Study. İKÇÜSBFD. 2023 Oct. 1;8(3):963-8. doi:10.61399/ikcusbfd.1245472

Cited By



Licensed under a Creative Commons Attribution 4.0 International License.